Autopsy report · NCT01822171
Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients
Cause of deathSlow enrollment
“Unable to enroll and study intended patient population.”
Life of this trial
- Ran for about 4 months before it stopped.
- 1 participant enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Providence Health & Services
- Sponsor type
- University, hospital or other
- Conditions
- Heart Failure
- Interventions
- Discharge medication counseling from a pharmacist; Home medication if needed; Follow-up visit at Medication Therapy Management clinic
- Participants
- 1
- Sites
- 2
- Countries
- United States
Trials that died the same way
- Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
“Unable to enroll patients into study.” - Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
“Unable to enroll patients.” - Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
“Unable to enroll appropriate patients” - Evaluation of the Efficacy of Bio-K+ Cl-1285® In the Nasal Decolonization of Methicillin Resistant Staphylococcus Aureus (MRSA) Carrier Patients
“Unable to recruit patients to continue on with the study.” - Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients
“Unable to enroll patients, no longer at institution.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.